DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 43 filers reported holding NEOS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$201,000
+18.2%
320,9930.0%0.00%0.0%
Q3 2020$170,000
-22.7%
320,9930.0%0.00%
-33.3%
Q2 2020$220,000
-8.7%
320,9930.0%0.01%
-25.0%
Q1 2020$241,000
-50.3%
320,9930.0%0.01%
-46.7%
Q4 2019$485,000
+2.1%
320,9930.0%0.02%
-21.1%
Q3 2019$475,000
+14.7%
320,9930.0%0.02%
+26.7%
Q2 2019$414,000
-91.2%
320,993
-82.2%
0.02%
-91.7%
Q1 2019$4,696,000
+131.3%
1,799,141
+46.2%
0.18%
+122.2%
Q4 2018$2,030,000
+39.2%
1,230,267
+427.3%
0.08%
+58.8%
Q2 2018$1,458,000
-79.7%
233,332
-73.0%
0.05%
-79.5%
Q1 2018$7,179,000
-5.6%
864,906
+16.0%
0.25%
-16.7%
Q4 2017$7,607,000
-47.0%
745,767
-52.5%
0.30%
-53.8%
Q3 2017$14,356,000
+34.8%
1,568,921
+7.5%
0.65%
+13.9%
Q2 2017$10,652,000
-29.5%
1,459,195
-30.5%
0.57%
-2.6%
Q1 2017$15,114,000
+1027.1%
2,099,166
+816.0%
0.58%
+960.0%
Q4 2016$1,341,000
-11.1%
229,1660.0%0.06%
-21.4%
Q3 2016$1,508,000
-64.5%
229,166
-50.0%
0.07%
-58.1%
Q2 2016$4,253,000
-14.0%
458,3320.0%0.17%
-20.9%
Q1 2016$4,945,000
-24.7%
458,3320.0%0.21%
-20.7%
Q4 2015$6,563,000
-31.8%
458,3320.0%0.27%
-28.7%
Q3 2015$9,630,000458,3320.37%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders